Peripheral Stent Market: Market Size & Forecast 2026

Peripheral stents are small, expandable metal or polymer tubes implanted in narrowed peripheral arteries to restore blood flow and prevent vessel collapse. The market covers stents used across multiple vascular territories including the femoral-popliteal, iliac, carotid, and renal arteries. Products range from bare-metal stents to drug-eluting stents (DES) and covered stents, with ongoing innovation focusing on improved deliverability through complex anatomies and reduced restenosis rates.

• •Treats peripheral artery disease (PAD), which affects over 200 million people globally
• •Includes bare-metal, drug-eluting, and covered stent technologies
• •Delivered via minimally invasive catheter-based procedures under imaging guidance

The rising global burden of PAD, driven by increasing rates of diabetes, obesity, smoking, and sedentary lifestyles, fuels demand for interventional treatments. An aging population worldwide further expands the patient pool eligible for peripheral vascular interventions. Additionally, improved clinical evidence supporting drug-eluting technologies over bare-metal alternatives has accelerated their adoption, while favorable reimbursement policies in developed markets support sustained procedure volume growth.

• •Growing prevalence of diabetes and cardiovascular risk factors across all regions
• •Aging demographics in developed nations creating sustained demand for vascular interventions
• •Superior clinical outcomes with drug-eluting stents driving category migration

The market is segmented by product type, including bare-metal stents, drug-eluting stents, and covered stents, as well as by vascular territory, femoral-popliteal, iliac, carotid, and renal applications. Geographically, North America commands the largest share due to high PAD awareness, advanced healthcare infrastructure, and favorable reimbursement frameworks, while Europe represents a substantial secondary market. The Asia-Pacific region is emerging as the fastest-growing segment, propelled by improving access to interventional procedures, rising chronic disease prevalence, and healthcare infrastructure expansion in China, India, and Southeast Asia.

• •Femoral-popliteal and iliac segments represent the largest volume categories
• •North America leads with approximately 35-40% of global market share
• •Asia-Pacific projected as the fastest-growing region through the decade

What are the recent trends and outlook?

The market is trending toward more specialized stent platforms tailored to specific vascular anatomies, with increasing emphasis on technologies that reduce restenosis and thrombosis rates. Ongoing investment in research and development spans dual antiplatelet therapy optimization, improved polymer biocompatibility, and imaging-guided delivery systems. As healthcare systems increasingly prioritize cost-effectiveness, competitive dynamics are expected to intensify, with value-based evidence and real-world outcomes playing a growing role in device selection and procurement decisions.

• •Drug-eluting and drug-coated technologies continue to displace bare-metal stents based on clinical evidence
• •Bioresorbable and polymer-free stent platforms under active development for long-term safety
• •Value-based contracting and health economic data increasingly influencing device procurement